Cargando…
Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination
The re-emerging threat of smallpox and the emerging threat of monkeypox highlight the need for effective poxvirus countermeasures. Currently approved smallpox vaccines have unacceptable safety profiles and, consequently, the general populace is no longer vaccinated, leading to an increasingly suscep...
Autores principales: | Grosenbach, Douglas W., Jordan, Robert, King, David S., Berhanu, Aklile, Warren, Travis K., Kirkwood-Watts, Dana L., Tyavanagimatt, Shanthakumar, Tan, Ying, Wilson, Rebecca L., Jones, Kevin F., Hruby, Dennis E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757089/ https://www.ncbi.nlm.nih.gov/pubmed/18226434 http://dx.doi.org/10.1016/j.vaccine.2007.11.095 |
Ejemplares similares
-
Development of ST-246® for Treatment of Poxvirus Infections
por: Jordan, Robert, et al.
Publicado: (2010) -
Pharmacokinetics and Interspecies Allometric Scaling of ST-246, an Oral Antiviral Therapeutic for Treatment of Orthopoxvirus Infection
por: Amantana, Adams, et al.
Publicado: (2013) -
Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge()()
por: Russo, Andrew T., et al.
Publicado: (2020) -
Comparison of the Safety and Pharmacokinetics of ST-246® after IV Infusion or Oral Administration in Mice, Rabbits and Monkeys
por: Chen, Yali, et al.
Publicado: (2011) -
Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf
por: De Clercq, Erik, et al.
Publicado: (2023)